Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant.
Disappearance
Pregnancy
Ulipristal acetate
Uterine fibroid
Journal
Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
18
01
2019
revised:
07
03
2019
accepted:
15
03
2019
pubmed:
23
3
2019
medline:
19
3
2020
entrez:
23
3
2019
Statut:
ppublish
Résumé
Uterine fibroids are the most common form of benign gynaecological tumors in women of childbearing age Piecak et al. (2017) [1]. These uterine fibroids can be responsible for abnormal uterine bleeding, pelvic pain, pelvic pressure and infertility Pritts et al. (2009), Ali and Al-Hendy (2017) [2,3]. Their treatment can be carried out according to several methods: medical treatment, uterine artery embolization or surgery (myomectomy or hysterectomy). Although surgery is the main option, there are medical treatments to reduce their size and decrease and control their symptoms. Ulipristal acetate (UPA) has been the first selective progesterone-receptor modulator approved for the preoperative and long-term treatment for uterine fibroids Ferrero et al. (2018) [4]. Here we present the case of a 38-years-old patient whose large fibroma (initially treated with UPA) totally disappeared after pregnancy.
Identifiants
pubmed: 30898625
pii: S2468-7847(19)30035-2
doi: 10.1016/j.jogoh.2019.03.015
pii:
doi:
Substances chimiques
Contraceptive Agents, Hormonal
0
Norpregnadienes
0
ulipristal acetate
YF7V70N02B
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
781-783Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.